Cash-rich Cam­bridge start­up Ru­bius to build $155M cell ther­a­py man­u­fac­tur­ing site in Rhode Is­land

Af­ter clos­ing two mega-rounds of in­vest­ment with­in eight months of each oth­er, the boom­ing team at Ru­bius is now putting some of that cash to work. The Cam­bridge start­up is build­ing out a 135,000 square-foot man­u­fac­tur­ing site in Rhode Is­land for its cell ther­a­pies — just months be­fore it files its first IND.

The com­pa­ny plans to ren­o­vate an ex­ist­ing prop­er­ty in Smith­field, RI to do the job, in­vest­ing $155 mil­lion over the next 5 years for the project. Back in March, Ru­bius’ pres­i­dent Tor­ben Straight Nis­sen told End­points News that he was pon­der­ing an in-house man­u­fac­tur­ing process. De­vel­op­ing a new class of med­i­cine calls ear­ly on for some pricey man­u­fac­tur­ing ca­pac­i­ty.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER